PATENT CLAIM ANALYSIS

Application Number: 15893546
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "465000"]

Abstract:
In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.

Claim (Index 7):
The method of  claim 1 , wherein administering the dosage form results in an improvement in one or more clinical parameters in the subject within two weeks from the first administration, wherein the parameters are selected from the group consisting of an increase in the percentage of vaginal superficial cells, a decrease in the percentage of vaginal parabasal cells, a decrease in vaginal pH, and a decrease in the severity of moderate to severe symptoms of dyspareunia.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 88.0
- Lexical Diversity: 1.21622
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15893542', '15372385', '15893550', '14521230', '14624051']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8400311271132006
- 35 USC 102 Novelty (BERT): 0.6479947787590641
- Combined Prediction Score: 0.8208274922777871
- Mean Citation Score: 552.7723100000002
- Max Citation Score: 690.2291
- Similarity Product: 590.4884324680925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test